Reference
Stickel F, et al. Bevacizumab for the treatment of Osler's disease - A note of caution. Liver International 37: 927-928, No. 6, Jun 2017. Available from: URL: http://doi.org/10.1111/liv.13361 - Switzerland
Rights and permissions
About this article
Cite this article
Bevacizumab. Reactions Weekly 1660, 79 (2017). https://doi.org/10.1007/s40278-017-33044-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-017-33044-z